ImmunoPET in Multiple Myeloma—What? So What? Now What?

Despite constant progress over the past three decades, multiple myeloma (MM) is still an incurable disease, and the identification of new biomarkers to better select patients and adapt therapy is more relevant than ever. Recently, the introduction of therapeutic monoclonal antibodies (mAbs) (includi...

全面介紹

Na minha lista:
書目詳細資料
發表在:Cancers (Basel)
Main Authors: Bailly, Clément, Chalopin, Benjamin, Gouard, Sébastien, Carlier, Thomas, Remaud-Le Saëc, Patricia, Marionneau-Lambot, Séverine, Moreau, Philippe, Touzeau, Cyrille, Kraeber-Bodere, Françoise, Bodet-Milin, Caroline, Chérel, Michel
格式: Artigo
語言:Inglês
出版: MDPI 2020
主題:
Perspective
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7352991/
https://ncbi.nlm.nih.gov/pubmed/32512883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12061467
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍